title: Treatment of graft failure after bone marrow transplantation.
authors.forename: T
authors.initials: T
authors.lastname: Yokota
authors.forename: A
authors.initials: A
authors.lastname: Tsuboi
authors.forename: Y
authors.initials: Y
authors.lastname: Okajima
authors.forename: Y
authors.initials: Y
authors.lastname: Oji
authors.forename: Y
authors.initials: Y
authors.lastname: Moriyama
authors.forename: T
authors.initials: T
authors.lastname: Tatekawa
authors.forename: T
authors.initials: T
authors.lastname: Karasuno
authors.forename: N
authors.initials: N
authors.lastname: Tominanga
authors.forename: H
authors.initials: H
authors.lastname: Tejima
authors.forename: A
authors.initials: A
authors.lastname: Hiraoka
mesh_terms: D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D005260:Female; D006084:Graft Rejection / Q000628:therapy*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D007375:Interleukin-1 / Q000627:therapeutic use; D007938:Leukemia / Q000628:therapy; D008297:Male; D008875:Middle Aged
chemical_list: D007375:Interleukin-1; D016179:Granulocyte Colony-Stimulating Factor